Insider Trading History of Three Arch Associates Iii Lp

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Three Arch Associates Iii Lp since 2006. The trader's CIK number is 1113520. At the time of the last reporting, Three Arch Associates Iii Lp was the 10% Owner of Acelrx Pharmaceuticals Inc. (stock ticker symbol ACRX). Also see all insider trading activities at Acelrx Pharmaceuticals Inc.

Note that in the past THREE ARCH ASSOCIATES III LP also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Molecular Templates, Inc. (THLD) by Three Arch Associates Iii Lp

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 THLD 0 $0 2,000,000 $29,000,000 0 $0

Yearly summary of insider trading at Acelrx Pharmaceuticals Inc (ACRX) by Three Arch Associates Iii Lp

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 ACRX 1,289,789 $6,448,945 0 $0 0 $0


Insider trading activities at 2 companies by Three Arch Associates Iii Lp:

1. Molecular Templates, Inc. (THLD)

2. Acelrx Pharmaceuticals Inc (ACRX)

Table 1. Insider trading of Molecular Templates, Inc. (THLD) by Three Arch Associates Iii Lp

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-03-03 THLD Sale 1,000,000 14.50 14,500,000
2006-03-03 THLD Sale 1,000,000 14.50 14,500,000

Table 2. Insider trading of Acelrx Pharmaceuticals Inc (ACRX) by Three Arch Associates Iii Lp

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-02-16 ACRX Buy 1,289,789 5.00 6,448,945

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Three Arch Associates Iii Lp (10% Owner of Acelrx Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.